Promising results for extended-release buprenorphine

A study has shown high treatment retention and adherence, reduced substance use and depression, and improved quality of life among those receiving monthly BUP-XR Community use of long-acting buprenorphine has shown positive findings after two years of follow up, according to Professor Michael Farrell, Director of the National Drug and Alcohol Research Centre (NDARC) at